It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMED’s FA Score shows that 0 FA rating(s) are green while.
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMED’s TA Score shows that 4 TA indicator(s) are bullish.
AMED (@Hospital/Nursing Management) experienced а +0.05% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +1.78%. For the same industry, the average monthly price growth was +0.43%, and the average quarterly price growth was +6.39%.
AMED is expected to report earnings on Oct 29, 2025.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
AMED | ||
---|---|---|
OUTLOOK RATING 1..100 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 79 | |
PRICE GROWTH RATING 1..100 | 51 | |
P/E GROWTH RATING 1..100 | 36 | |
SEASONALITY SCORE 1..100 | 39 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMED | MARB | |
---|---|---|
RSI ODDS (%) | 3 days ago33% | 7 days ago63% |
Stochastic ODDS (%) | 3 days ago51% | 3 days ago48% |
Momentum ODDS (%) | 3 days ago44% | 3 days ago62% |
MACD ODDS (%) | 3 days ago37% | 3 days ago52% |
TrendWeek ODDS (%) | 3 days ago44% | 3 days ago55% |
TrendMonth ODDS (%) | 3 days ago35% | 3 days ago55% |
Advances ODDS (%) | 4 days ago47% | 3 days ago49% |
Declines ODDS (%) | 17 days ago58% | 28 days ago50% |
BollingerBands ODDS (%) | 3 days ago53% | 3 days ago51% |
Aroon ODDS (%) | 3 days ago28% | N/A |
A.I.dvisor tells us that AMED and FMCQF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMED and FMCQF's prices will move in lockstep.
Ticker / NAME | Correlation To AMED | 1D Price Change % | ||
---|---|---|---|---|
AMED | 100% | N/A | ||
FMCQF - AMED | 24% Poorly correlated | -0.11% | ||
OPCH - AMED | 23% Poorly correlated | -0.32% | ||
EHAB - AMED | 21% Poorly correlated | +2.30% | ||
USPH - AMED | 21% Poorly correlated | -0.23% | ||
BKD - AMED | 20% Poorly correlated | -0.27% | ||
More |
A.I.dvisor tells us that MARB and CPRI have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MARB and CPRI's prices will move in lockstep.
Ticker / NAME | Correlation To MARB | 1D Price Change % | ||
---|---|---|---|---|
MARB | 100% | +0.01% | ||
CPRI - MARB | 24% Poorly correlated | -1.97% | ||
ACI - MARB | 16% Poorly correlated | +0.68% | ||
SRDX - MARB | 15% Poorly correlated | -0.48% | ||
CHX - MARB | 14% Poorly correlated | N/A | ||
K - MARB | 9% Poorly correlated | +0.14% | ||
More |